Impact & Social Good Series A Investors & VC Firms
828 firms in this list, with a median first check of $500K. 151 of them lead rounds. Generated from verified public data and updated continuously.
NGEN Partners
New YorkSeed–Growth$5M – $20M
4 people
Renew Capital
DenverSeed–Series A
4 people
Cure Kids Ventures
AucklandSeed–Series A
6 people
LDR Ventures
Los AngelesPre-Seed–Series A
4 people
Feelsgood Capital Partners
ZagrebSeed–Growth
8 people
Hatzimemos/Libby
New YorkPre-Seed–Growth$10K – $1.5M
5 people
Nuance Capital
Takapuna, AucklandSeed–Series B
8 people
Vespucci Partners
BudapestSeed–Series A$648K – $4.9M
5 people
Accelia Capital
MontrealSeed–Series A$219K – $730K
7 people
FINCA Ventures
WashingtonSeed–Series A
4 people
FFF
UtrechtPre-Seed–Series A
6 people
NSW Clean Technology Innovation Grants
SydneySeed–Series A$500K – $5M
Simpact Ventures
WarszawaPre-Seed–Series A$500K – $2M
6 people
Better Food Ventures
Silicon ValleyPre-Seed–Series A
5 people
Incite.org
San FranciscoPre-Seed–Series A
5 people
The W Fund
New YorkSeed–Series A
9 people
Future Positive Capital
Pre-Seed–Series A
4 people
Emend Vision Fund
VictoriaSeed–Series A
10 people
Overboost
Vicente LópezPre-Seed–Series A
12 people
SIDBI Venture Capital
MumbaiSeed–Growth
6 people
Wollemi Capital
SydneySeries A–Series B
9 people
WXR Fund
San FranciscoSeed–Series A$100K – $1M
4 people
Belle Impact Fund
Grosse Pointe FarmsSeed–Series A$25K – $250K
3 people
Light Warrior Group
ToorakSeries A–Growth
9 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)Series A Investors & VC Firms in Global (2210)
Data sourced from public filings and firms' own websites — see our methodology.



























































































